BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4297684)

  • 21. Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis.
    Sebastian A; Schambelan M; Sutton JM
    Am J Nephrol; 1984; 4(5):287-300. PubMed ID: 6524600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fludrocortisone for the treatment of heparin-induced hyperkalemia.
    Sherman DS; Kass CL; Fish DN
    Ann Pharmacother; 2000 May; 34(5):606-10. PubMed ID: 10852087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyperkalemic, hyperchloremic acidosis in moderate chronic renal insufficiency and selective hypoaldosteronism].
    Caron C; Nawar T; Montambault P; Plante GE; Kandalaft N
    Union Med Can; 1977 Dec; 106(12):1640-4. PubMed ID: 601918
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperkalemic distal renal tubular acidosis and selective aldosterone deficiency. Combination in a patient with lead nephropathy.
    Ashouri OS
    Arch Intern Med; 1985 Jul; 145(7):1306-7. PubMed ID: 4015282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis.
    Furuya R; Kumagai H; Sakao T; Maruyama Y; Hishida A
    Nephron; 2002; 92(3):576-81. PubMed ID: 12372940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of hyperkalemia with fludrocortisone in a patient with systemic lupus erythematosus.
    Dreyling KW; Wanner C; Schollmeyer P
    Clin Nephrol; 1990 Apr; 33(4):179-83. PubMed ID: 2350905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudohypoaldosteronism: case report and discussion of the syndrome.
    Throckmorton DC; Bia MJ
    Yale J Biol Med; 1991; 64(3):247-54. PubMed ID: 1788991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue renin angiotensin systems: theoretical implications for the development of hyperkalemia using angiotensin-converting enzyme inhibitors.
    Schlueter W; Keilani T; Batlle DC
    Am J Med Sci; 1994 Feb; 307 Suppl 1():S81-6. PubMed ID: 8141171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment and prevention of hyperkalemia in end-stage renal disease.
    Allon M
    Kidney Int; 1993 Jun; 43(6):1197-209. PubMed ID: 8315933
    [No Abstract]   [Full Text] [Related]  

  • 30. Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease.
    Singhal PC; Desroches L; Mattana J; Abramovici M; Wagner JD; Maesaka JK
    Am J Nephrol; 1993; 13(2):138-41. PubMed ID: 8342580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperkalemia provoked by acute hepatic necrosis.
    Bercovitch DD; Davidman M; Lichter M
    Am J Nephrol; 1986; 6(4):296-301. PubMed ID: 3777039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Type IV renal tubular acidosis: pathogenetic role of aldosterone deficiency and hyperkalemia].
    Schambelan M; Sebastian A
    Nephrologie; 1985; 6(3):135-7. PubMed ID: 3908957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [beta-Sympathomimetics against hyperkalemia in kidney failure].
    Rambausek M; Kluge R
    Dtsch Med Wochenschr; 1993 Jan; 118(4):120-1. PubMed ID: 8428555
    [No Abstract]   [Full Text] [Related]  

  • 34. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
    Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K
    Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occult adrenal insufficiency secondary to amyloidosis in the context of chronic renal failure.
    Harvey CJ; Gower PE; Hawkins PN; Pepys MB; Phillips ME
    Nephrol Dial Transplant; 1995; 10(7):1237-9. PubMed ID: 7478132
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pure hypoaldosteronism in the adult].
    Benoit G
    Lille Med; 1975 Feb; 20(2):142-51. PubMed ID: 238088
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyporeninemic hypoaldosteronism in a child with chronic kidney disease--is this condition renoprotective?
    Lee BH; Kang HG; Choi Y
    Pediatr Nephrol; 2009 Sep; 24(9):1771-2. PubMed ID: 19189133
    [No Abstract]   [Full Text] [Related]  

  • 38. Syndrome of hyporeninemic hypoaldosteronism. Study of two cases and review of the literature.
    Brezis M; Litvin Y
    Isr J Med Sci; 1977 Oct; 13(10):1013-21. PubMed ID: 591294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperkalemia unresponsive to massive doses of aldosterone in a patient with renal tubular acidosis.
    Radó JP; Szende L; Szücs L
    Endokrinologie; 1976; 68(2):183-8. PubMed ID: 1009902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperkalemia unresponsive to massive doses of aldosterone and renal tubular acidosis in a patient with chronic interstitial nephritis: clinical and experimental studies.
    Radó JP; Szende L; Szucs L
    J Med; 1976; 7(6):481-510. PubMed ID: 188961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.